CHARLES SCHWAB INVESTMENT MANAGEMENT INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2021$772,000
+4.7%
181,934
-4.1%
0.00%
Q4 2020$737,000
-3.7%
189,7850.0%0.00%
Q3 2020$765,000
-35.4%
189,785
-31.8%
0.00%
-100.0%
Q2 2020$1,185,000
+109.7%
278,154
+106.9%
0.00%
Q1 2020$565,000
+21.0%
134,454
+13.2%
0.00%
Q4 2019$467,000
-59.0%
118,788
-8.2%
0.00%
-100.0%
Q3 2019$1,139,000
-2.8%
129,365
+2.1%
0.00%0.0%
Q2 2019$1,172,000
+81.1%
126,698
+26.1%
0.00%
Q1 2019$647,000
-40.3%
100,504
-12.5%
0.00%
-100.0%
Q4 2018$1,083,000
-49.5%
114,809
+7.7%
0.00%0.0%
Q3 2018$2,146,000
-32.9%
106,580
-2.7%
0.00%
-50.0%
Q2 2018$3,197,000
+24.2%
109,580
+26.8%
0.00%0.0%
Q1 2018$2,574,000
+6.2%
86,430
+14.8%
0.00%0.0%
Q4 2017$2,424,000
+7.8%
75,298
+16.5%
0.00%0.0%
Q3 2017$2,249,000
+169.0%
64,659
+130.3%
0.00%
+100.0%
Q2 2017$836,000
+29.6%
28,079
+30.1%
0.00%0.0%
Q1 2017$645,000
+70.2%
21,5790.0%0.00%
Q4 2016$379,000
-26.3%
21,5790.0%0.00%
-100.0%
Q3 2016$514,000
+48.6%
21,5790.0%0.00%
Q2 2016$346,000
-23.5%
21,5790.0%0.00%
-100.0%
Q1 2016$452,000
-22.5%
21,5790.0%0.00%0.0%
Q4 2015$583,000
+26.5%
21,579
+30.2%
0.00%0.0%
Q3 2015$461,000
+13.3%
16,5790.0%0.00%0.0%
Q2 2015$407,00016,5790.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders